Pete from Shawnee Mission wrote: “I am not going to run around doing a survey of doctors on this subject and I suspect you did not either before making your statement.”
Because you know that this is a very minority opinion. I provided material from credible sources that demonstrates that this can be dangerous and ineffective.
Pete from Shawnee Mission wrote: “Reuters agrees with you. Because we all should trust Reuters like we should trust Facebook like we should trust the Washington Post.”
Pete from Shawnee Mission wrote: “Same story from another source.”
Interesting. You challenge the credibility of Reuters then you cite AFLD, one of whose spokespersons asserts that demons impregnate women while the sleep.
Pete from Shawnee Mission wrote: “Sorry D. Duke, the Covid vaccines do NOT stop transmission, do NOT stop death (Ivermectin....1 documented death in 40 years of use though. Dangerous!)”
Talk about a strawman argument. There are no vaccines that stop all transmissions and stop all deaths. Ivermectin is dangerous and ineffective. There are no credible, peer reviewed studies that show ivermectin is as effective as the vaccines in stopping transmissions and deaths.
Pete from Shawnee Mission wrote: “Snip.... “Federal Prison Study Finds Vaccinated Just As Infectious As Unvaccinated: The study found that vaccinated prisoners were just as infectious as unvaccinated prisoners and there was no difference in the length of sickness between the vaccinated and unvaccinated.”
In order for a vaccinated person to become infectious, the first have to become infected and the chances of an vaccinated person becoming infected is far less than the chances of an unvaccinated person.
Pete from Shawnee Mission wrote: “So, D.D. You are promoting the use of dangerous EULA vaccines by the FDA & CDC. Someone at these organizations is making money from them and suppressing use of actual treatments to allow the EULA designation.”
The Pfizer vaccine is fully approved so there is no reason to ‘suppress use of actual treatments to allow the EULA designation.’
D.D. Thanks for your reply! (I think your tagline is mostly correct!)
D.D wrote
“Because you know that this is a very minority opinion. I provided material from credible sources that demonstrates that this can be dangerous and ineffective”.
As I noted your argument was an “Ad Populam” argument based on the logical fallacy that because most doctors (do not yet) believe a link between palm oil and cancer spread it must be false. (It may also be that they are not aware of it but that is a different issue.)
D.D. “Interesting. You challenge the credibility of Reuters then you cite AFLD, one of whose spokespersons asserts that demons impregnate women while the sleep.
Could be fake attribution or deliberate distortion of what someone said. This happened regularly to President Trump, didn’t it? They kept asking why he did not denounce white nationalism after he did. Something media does regularly, mis-state to confuse and mislead.
Since you offer the charge, please provide the name of the AFLD person and a link to them actually stating or saying that demons impregnate sleeping women. (Are they a good doctor in other ways??)
D.D. “Talk about a strawman argument. There are no vaccines that stop all transmissions and stop all deaths. (Thank you for conceding this point.) Ivermectin is dangerous and ineffective. There are no credible, peer reviewed studies that show ivermectin is as effective as the vaccines in stopping transmissions and deaths.”
See below. Ivermectin. Not ineffective, not dangerous, Must be used early. Widely used where Fauchi and the Drug Companies are not running things.
(Peer reviewed as noted. You can also select other covid treatments in the drop down box. nice! )
Early, Late, PrEP, PEP Covid Analysis (Preprint) (meta analysis) meta-analysis v155 Ivermectin for COVID-19: real-time meta analysis of 67 studies
Details • Statistically significant improvements are seen for mortality, ventilation, ICU admission, hospitalization, recovery, cases, and viral clearance. All remain statistically significant after exclusions. 45 studies show statistically signi..
Nov 23 Late Ozer et al., Journal of Medical Virology, doi:10.1002/jmv.27469 (Peer Reviewed) death, ↓75.0%, p=0.09 Effectiveness and Safety of Ivermectin in COVID‐19 Patients: A Prospective Study at A Safety‐Net Hospital
Details Small prospective PSM study in the USA, showing 75% lower mortality with ivermectin treatment, without reaching statistical significance, significantly shorter ventilation and ICU time, and longer hospitalization time. Authors leave the ..
Nov 17 PrEPPEP Samajdar et al., Journal of the Association of Physicians India, 69:11 (Peer Reviewed) cases, ↓79.8%, p<0.0001 Ivermectin and Hydroxychloroquine for Chemo-Prophylaxis of COVID-19: A Questionnaire Survey of Perception and Prescribing Practice of Physicians vis-a-vis Outcomes
Details Physician survey in India with 164 ivermectin prophylaxis, 129 HCQ prophylaxis, and 81 control patients, showing significantly lower COVID-19 cases with treatment. Details of the treatment and control groups and the definition of cases ar..
Nov 9 Late Stone et al., Research Square, doi:10.21203/rs.3.rs-1048271/v1 (Preprint)
Rapid increase of SpO2 on room air for 34 severe COVID-19 patients after ivermectin-based combination treatment: 55-62% normalization within 12-24 hours
Details Retrospective severe COVID-19 patients in Zimbabwe treated with ivermectin, doxycycline, and zinc. For 34 with SpO2 tracking, there was rapid improvement in SpO2, with 55% recovery towards SpO2=97 within 12 hours. For all 92 severe cases,..
Nov 3 Late Malaysia Ministry of Health (News) death, ↓69.1%, p=0.09 Kenyataan Akhbar KPK 3 November 2021 – Hasil Dapatan Kajian Keberkesanan Rawatan Ivermectin Untuk Pesakit COVID-19 Berisiko Tinggi (I-TECH Study)
Details RCT 490 hospitalized patients in Malaysia, showing no significant differences. There was only 13 deaths - 3 for ivermectin and 10 for control. Minimal details are available currently. Group sizes are not provided (241/249 are the closest ..
Oct 28 PrEPPEP Verma et al., Indian Journal of Community Health, 33:3 (Peer Reviewed) Assessing Knowledge, Attitude, and Practices towards Ivermectin Pre-exposure Prophylaxis for COVID-19 among Health Care Workers
Details Survey of 306 healthcare workers involved in the medication of COVID-19 patients in India. 71% indicated that ivermectin had a protective effect for COVID-19.
Oct 20 Review Low et al., Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, doi:10.1016/j.bbadis.2021.166294 (Review) (Peer Reviewed) review Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication
Details Review of the antiviral characteristics of ivermectin and mechanisms of action. Authors note that ivermectin has proven effective for HIV-1, Adenovirus, flu, SARS-CoV, and more; due to genomic similarity between SARS-CoV-2 and SARS-CoV, t..
Oct 19 Early Borody et al., TrialSite News (Preprint) death, ↓92.3%, p=0.03 Combination Therapy For COVID-19 Based on Ivermectin in an Australian Population
Details Retrospective 600 PCR+ outpatients in Australia treated with ivermectin, zinc, and doxycycline, showing significantly lower mortality and hospitalization with treatment. This trial uses a synthetic control group, and the preliminary repor..
Oct 15 In Vitro Segatori et al., Viruses, doi:10.3390/v13102084 (Peer Reviewed) (In Vitro) in vitro Effect of Ivermectin and Atorvastatin on Nuclear Localization of Importin Alpha and Drug Target Expression Profiling in Host Cells from Nasopharyngeal Swabs of SARS-CoV-2- Positive Patients
Details Gene expression analysis of nasopharyngeal swabs of COVID-19 positive and negative patients, and in vitro study supporting the use of ivermectin and atorvastatin for COVID-19, and the efficacy of ivermectin at clinically relevant dosages...
Oct 14 In Vitro Jitaboam et al., Research Square, doi:10.21203/rs.3.rs-941811/v1 (Peer Reviewed) (In Vitro) in vitro Favipiravir and Ivermectin Showed in Vitro Synergistic Antiviral Activity against SARS-CoV-2
Details In Vitro study showing a strong synergistic effect of ivermectin and favipiravir. Combining multiple antiviral drugs with different mechanisms of action helps to minimize drug resistance and toxicity.
Oct 14 News Goodkin, M. (News) news Are Major Ivermectin Studies Designed for Failure?
News Goodkin, M. (News)
news
Are Major Ivermectin Studies Designed for Failure?
Details Discussion of flaws in ivermectin trials creating a bias towards not finding an effect.
(These are he most recent articles. More showing at link.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(05)62668-2/fulltext
Note the second paragraph.
D.D. “In order for a vaccinated person to become infectious, the first have to become infected and the chances of an vaccinated person becoming infected is far less than the chances of an unvaccinated person.”
I would agree but I do not think the vaccines are very effective or they would not be wanting multiple boosters. I would also indicate that the varients are originating in the vaccinated. (I will not raise the issue of natural immunity here!)
DD “The Pfizer vaccine is fully approved so there is no reason to ‘suppress use of actual treatments to allow the EULA designation.’”
I think are doing a bit of bait and switch here. I may respond at a later time!.
Have a good day!
Pete from Shawnee Mission wrote: “So, D.D. You are promoting the use of dangerous EULA vaccines by the FDA & CDC. Someone at these organizations is making money from them and suppressing use of actual treatments to allow the EULA designation.”
D.D. "The Pfizer vaccine is fully approved so there is no reason to ‘suppress use of actual treatments to allow the EULA designation.’"
To reiterate, the Pfizer vaccine is not approved, it is EULA. Comirnaty is approved. All this is is a little jiggery-pokery trying to pass one off as the other.
https://childrenshealthdefense.org/defender/judge-allen-winsor-pfizer-eua-comirnaty-vaccines-interchangeable/
"Federal Judge Rejects DOD Claim That Pfizer EUA and Comirnaty Vaccines Are ‘Interchangeable’
A federal district court judge has rejected a claim by the U.S. Department of Defense (DOD) that the Pfizer-BioNTech COVID-19 vaccine being administered under Emergency Use Authorization is interchangeable with Pfizer’s Comirnaty vaccine, which in August was fully licensed by the U.S. Food and Drug Administration (FDA).
In an order issued Nov. 12 in Doe et al. v. Austin, U.S. Federal District Judge Allen Winsor of the U.S. District Court for the Northern District of Florida denied a preliminary injunction requested by 16 service members against the U.S. Military’s COVID vaccine mandate. A hearing is scheduled for Sept. 14, 2022.
However, the judge’s acknowledgment that “the DOD cannot mandate vaccines that only have an EUA” is significant for two reasons.
One reason pertains to the difference in ingredients and manufacturing process between Pfizer’s EUA vaccine and the approved Comirnaty vaccine, and the other pertains to the legal difference between a fully licensed vaccine and an EUA vaccine.
The latter reason would apply not just to the Pfizer-BioNTech vaccine, but also to the vaccines produced by Moderna and Johnson & Johnson (Janssen), both of which are authorized only as EUA products."